Replies to post #13413 on Mast Therapeutics, Inc. (MSTX)

[TrailTeam]

I agree. Even with low volume, according to NASDAQ, 46% of all shares traded Friday were short.

The 9/15 "bi-monthly" short interest report showed MSTX at 19.8 Million or 17 days to cover. The 9/30 shows 20.6 Million short shares, but with increased volume of late making 11.4 days to cover.

I was expecting a reduction in short shares with AD and increased volume, but I think we payed the price for the IBB sell off and funds dumping Bio's for the last two weeks.

Thoughts??

TT